Trial Profile

A registrational trial to determine clinical outcomes of PRT-3789

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 14 Jul 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs PRT 3789 (Primary)
Indications Unspecified
Focus Registrational; Therapeutic Use

Most Recent Events

14 Jul 2024 New trial record
09 Jul 2024 According to a Prelude Therapeutics media release, phase 1 clinical study of PRT3789 as both monotherapy and in combination with docetaxel, are to establish a dose and potential indications for advancement into a registrational clinical trial.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com